Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria

NEEDHAM, MA, USA, August 19, 2014 /EINPresswire.com/ -- Insight Pharma Reports announces Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria. This report covers evolutionary growth of antibiotic resistant bacteria with a focus in research aspects, commercial aspects, market aspects, and trends in antibiotic resistance.

Highlighted in this report are the following concepts:

• History, status, and progress of drug resistant bacteria
• Evolution of today’s antibiotic resistant bacteria
• Diagnostic and therapeutic research programs directed at alleviating medical problems caused by antibiotic resistant bacteria
• Survey results exploiting commercial diagnostic and therapeutic programs and market-related aspects of antibiotic resistance
• Trends developing in the field
• Exclusive interviews with six individuals who are highly knowledgeable in the subject area

For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com or contact Kerri Kelley at kkelley@healthtech.com or 781-972-1347.

About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com

Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/affiliatedreports/

Kerri Kelley
Insight Pharma Reports
781-972-1347
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.